Citius Pharmaceuticals (CTXR)
(Delayed Data from NSDQ)
$0.47 USD
-0.03 (-6.49%)
Updated Oct 1, 2024 04:00 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 1/3/25 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | -20.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.21 |
Next Year | 0.09 |
EPS (TTM) | -0.24 |
P/E (F1) | 5.20 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 121.30M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 121.30M |
Low Estimate | NA | NA | NA | 121.30M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | NA | -0.21 | 0.09 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | -0.05 | NA | -0.21 | 0.09 |
High Estimate | -0.05 | NA | -0.21 | 0.09 |
Low Estimate | -0.05 | NA | -0.21 | 0.09 |
Year ago EPS | -0.07 | -0.06 | -0.24 | -0.21 |
Year over Year Growth Est. | 28.57% | NA | 12.50% | 142.86% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.05 | NA | -0.21 | 0.09 |
7 Days Ago | -0.05 | NA | -0.21 | 0.09 |
30 Days Ago | -0.05 | NA | -0.21 | 0.09 |
60 Days Ago | -0.05 | NA | -0.21 | 0.09 |
90 Days Ago | -0.05 | NA | -0.21 | 0.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | NA | -0.21 | 0.09 |
Zacks Consensus Estimate | -0.05 | NA | -0.21 | 0.09 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.05 | -0.06 | -0.07 | NA |
Estimate | -0.05 | -0.06 | 0.13 | NA | NA |
Difference | -0.01 | 0.01 | -0.19 | NA | -0.06 |
Surprise | -20.00% | 16.67% | -146.15% | NA | -49.83% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more